Cargando…
GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients
Obesity is an important risk factor and a potential treatment target for hepatic steatosis. The maladaptation of hepatic mitochondrial flexibility plays a key role in the hepatic steatosis. Herein, we found that hepatocyte-like cells derived from human adipose stem cell of obese patients exhibited t...
Autores principales: | Li, Yaqiong, Lin, Yi, Han, Xueya, Li, Weihong, Yan, Wenmao, Ma, Yuejiao, Lu, Xin, Huang, Xiaowu, Bai, Rixing, Zhang, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900441/ https://www.ncbi.nlm.nih.gov/pubmed/33665568 http://dx.doi.org/10.1016/j.isci.2021.102149 |
Ejemplares similares
-
Blockade of TGF-β signalling alleviates human adipose stem cell senescence induced by native ECM in obesity visceral white adipose tissue
por: Han, Xueya, et al.
Publicado: (2023) -
α5 integrin regulates hepatic tight junctions through SRC-TET1-mediated DNA hydroxymethylation
por: Ma, Yuejiao, et al.
Publicado: (2022) -
Activation of Wnt/β-catenin signalling via GSK3 inhibitors direct differentiation of human adipose stem cells into functional hepatocytes
por: Huang, Jieqiong, et al.
Publicado: (2017) -
Steatosis Alters the Activity of Hepatocyte Membrane Transporters in Obese Rats
por: Pastor, Catherine M., et al.
Publicado: (2021) -
Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease
por: Wang, Huan, et al.
Publicado: (2023)